Heska Corporation (HSKA)
US42805E3062 - Common Stock
Overall HSKA gets a fundamental rating of 3 out of 10. We evaluated HSKA against 192 industry peers in the Health Care Equipment & Supplies industry. While HSKA seems to be doing ok healthwise, there are quite some concerns on its profitability. HSKA is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
HSKA had negative earnings in the past year.
HSKA had a negative operating cash flow in the past year.
HSKA had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HSKA reported negative operating cash flow in multiple years.
1.2 Ratios
The profitability ratios for HSKA are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HSKA has a worse Gross Margin (42.93%) than 62.02% of its industry peers.
HSKA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for HSKA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
HSKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HSKA has more shares outstanding
Compared to 5 years ago, HSKA has more shares outstanding
The debt/assets ratio for HSKA has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.79 indicates that HSKA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.79, HSKA is doing good in the industry, outperforming 75.48% of the companies in the same industry.
HSKA has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
HSKA has a Debt to Equity ratio (0.23) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.79 |
ROIC/WACCN/A
WACC9.05%
2.3 Liquidity
A Current Ratio of 5.64 indicates that HSKA has no problem at all paying its short term obligations.
HSKA has a better Current ratio (5.64) than 70.67% of its industry peers.
A Quick Ratio of 4.12 indicates that HSKA has no problem at all paying its short term obligations.
HSKA has a better Quick ratio (4.12) than 68.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.12 |
3. Growth
3.1 Past
HSKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.97%.
Looking at the last year, HSKA shows a decrease in Revenue. The Revenue has decreased by -1.22% in the last year.
HSKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.75% yearly.
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y14.75%
Revenue growth Q2Q-3.73%
3.2 Future
HSKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.44% yearly.
Based on estimates for the next years, HSKA will show a small growth in Revenue. The Revenue will grow by 7.79% on average per year.
EPS Next Y55.25%
EPS Next 2Y40.17%
EPS Next 3Y27.58%
EPS Next 5Y26.44%
Revenue Next Year9.92%
Revenue Next 2Y9.98%
Revenue Next 3Y9.67%
Revenue Next 5Y7.79%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
HSKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSKA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HSKA's earnings are expected to grow with 27.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y27.58%
5. Dividend
5.1 Amount
No dividends for HSKA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Heska Corporation
NASDAQ:HSKA (6/12/2023, 7:00:01 PM)
After market: 119.99 0 (0%)119.99
+0.05 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.31B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.93% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.12 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y55.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y